These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5507168)

  • 1. [New drugs used in U.S.A. in 1969].
    Ravina A
    Presse Med (1893); 1970 Sep; 78(40):1747-8. PubMed ID: 5507168
    [No Abstract]   [Full Text] [Related]  

  • 2. Obama takes action on drugs shortages.
    Roehr B
    BMJ; 2011 Nov; 343():d7158. PubMed ID: 22051520
    [No Abstract]   [Full Text] [Related]  

  • 3. Products in the U.S. pipeline. Pharmaceutical Manufacturers Association.
    Biotechnology (N Y); 1991 Oct; 9(10):947-9. PubMed ID: 1367805
    [No Abstract]   [Full Text] [Related]  

  • 4. Upon closer inspection. As the U.S. imports more drugs and devices, the FDA's overseas initiatives aim to head off trouble at the source.
    Rhea S
    Mod Healthc; 2009 Mar; 39(13):28-30. PubMed ID: 19405431
    [No Abstract]   [Full Text] [Related]  

  • 5. New drugs: the AMA and the FDA.
    Appel JZ
    Ann Allergy; 1966 Jul; 24(7):333-6. PubMed ID: 5941864
    [No Abstract]   [Full Text] [Related]  

  • 6. New drugs and the Kefauver-Harris amendment.
    Krantz JC
    J New Drugs; 1966; 6(2):77-9. PubMed ID: 5917906
    [No Abstract]   [Full Text] [Related]  

  • 7. Issues in bringing new drugs to the market.
    Tracey WR
    Science; 2005 Dec; 310(5753):1425-6; author reply 1425-6. PubMed ID: 16329172
    [No Abstract]   [Full Text] [Related]  

  • 8. Macro trends in pharmaceutical innovation.
    Cohen FJ
    Nat Rev Drug Discov; 2005 Jan; 4(1):78-84. PubMed ID: 15688075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New drugs and product approvals from 2000.
    Taylor SE; Gage TW
    Tex Dent J; 2001 Nov; 118(11):1070-81. PubMed ID: 11806330
    [No Abstract]   [Full Text] [Related]  

  • 10. The year's new drugs.
    Rodman MJ
    RN; 1979 Jan; 42(1):33-46. PubMed ID: 252135
    [No Abstract]   [Full Text] [Related]  

  • 11. International research agreement leads to new U.S. guidelines.
    Maloney DM
    Hum Res Rep; 1995 Apr; 10(4):1-2. PubMed ID: 11654182
    [No Abstract]   [Full Text] [Related]  

  • 12. The evolution of new drug legislation.
    Kelsey FO
    BMQ; 1966 Sep; 17(3):72-81. PubMed ID: 5978212
    [No Abstract]   [Full Text] [Related]  

  • 13. When drugs are in short supply.
    Zurlinden J
    Nurs Spectr (Wash D C); 1999 Feb; 9(4):15-6. PubMed ID: 10542818
    [No Abstract]   [Full Text] [Related]  

  • 14. What's our pharmacologic readiness against a bioterrorism attack?
    Bucci KK; Briscoe-Dwyer L
    JAAPA; 2002 Apr; 15(4):10, 13. PubMed ID: 12012583
    [No Abstract]   [Full Text] [Related]  

  • 15. Problems relating to investigational drugs.
    Kelsey O
    Pharmakotherapia; 1964; 2(1):208-12. PubMed ID: 5875715
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs of limited commercial value.
    Van Woert MH
    N Engl J Med; 1980 Jul; 303(2):114. PubMed ID: 7383068
    [No Abstract]   [Full Text] [Related]  

  • 17. Biopharmaceutic equivalency and the role of the Food & Drug Administration.
    Hodges RM
    Am J Hosp Pharm; 1968 Mar; 25(3):121-7. PubMed ID: 5658859
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation and use of drug master files in the pharmaceutical industry.
    Personeus GR; Ascione P
    J Parenter Sci Technol; 1981; 35(2):63-9. PubMed ID: 7229835
    [No Abstract]   [Full Text] [Related]  

  • 19. U.S. study of drug effectiveness could bring new drug recalls.
    Bowles GC
    Mod Hosp; 1966 Aug; 107(2):128. PubMed ID: 5952736
    [No Abstract]   [Full Text] [Related]  

  • 20. New York State and drug lists: a history of confusion.
    Stetler CJ
    Med Mark Media; 1978 Sep; 13(9):36, 38, 40 passim. PubMed ID: 10316687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.